192 related articles for article (PubMed ID: 28631176)
41. Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms.
Polprasert C; Schulze I; Sekeres MA; Makishima H; Przychodzen B; Hosono N; Singh J; Padgett RA; Gu X; Phillips JG; Clemente M; Parker Y; Lindner D; Dienes B; Jankowsky E; Saunthararajah Y; Du Y; Oakley K; Nguyen N; Mukherjee S; Pabst C; Godley LA; Churpek JE; Pollyea DA; Krug U; Berdel WE; Klein HU; Dugas M; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Yoshida K; Ogawa S; Müller-Tidow C; Maciejewski JP
Cancer Cell; 2015 May; 27(5):658-70. PubMed ID: 25920683
[TBL] [Abstract][Full Text] [Related]
42. ETV6 and NOTCH1 germline variants in adult acute leukemia.
Dirse V; Norvilas R; Gineikiene E; Matuzevičienė R; Griskevicius L; Preiksaitiene E
Leuk Lymphoma; 2018 Apr; 59(4):1022-1024. PubMed ID: 28776427
[No Abstract] [Full Text] [Related]
43. GATA2 and secondary mutations in familial myelodysplastic syndromes and pediatric myeloid malignancies.
Wang X; Muramatsu H; Okuno Y; Sakaguchi H; Yoshida K; Kawashima N; Xu Y; Shiraishi Y; Chiba K; Tanaka H; Saito S; Nakazawa Y; Masunari T; Hirose T; Elmahdi S; Narita A; Doisaki S; Ismael O; Makishima H; Hama A; Miyano S; Takahashi Y; Ogawa S; Kojima S
Haematologica; 2015 Oct; 100(10):e398-401. PubMed ID: 26022708
[No Abstract] [Full Text] [Related]
44. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome).
Ostergaard P; Simpson MA; Connell FC; Steward CG; Brice G; Woollard WJ; Dafou D; Kilo T; Smithson S; Lunt P; Murday VA; Hodgson S; Keenan R; Pilz DT; Martinez-Corral I; Makinen T; Mortimer PS; Jeffery S; Trembath RC; Mansour S
Nat Genet; 2011 Sep; 43(10):929-31. PubMed ID: 21892158
[TBL] [Abstract][Full Text] [Related]
45. DDX41: the poster child for familial MDS/AML grows up.
Truong P; Pimanda JE
Blood; 2023 Feb; 141(5):447-449. PubMed ID: 36729548
[No Abstract] [Full Text] [Related]
46. Targeted gene correction of RUNX1 in induced pluripotent stem cells derived from familial platelet disorder with propensity to myeloid malignancy restores normal megakaryopoiesis.
Iizuka H; Kagoya Y; Kataoka K; Yoshimi A; Miyauchi M; Taoka K; Kumano K; Yamamoto T; Hotta A; Arai S; Kurokawa M
Exp Hematol; 2015 Oct; 43(10):849-57. PubMed ID: 26021490
[TBL] [Abstract][Full Text] [Related]
47. DDX41: the poster child for familial AML.
Rio-Machin A; Fitzgibbon J
Blood; 2022 Aug; 140(7):667-669. PubMed ID: 35980681
[No Abstract] [Full Text] [Related]
48. ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events.
Haferlach C; Bacher U; Schnittger S; Alpermann T; Zenger M; Kern W; Haferlach T
Genes Chromosomes Cancer; 2012 Apr; 51(4):328-37. PubMed ID: 22162288
[TBL] [Abstract][Full Text] [Related]
49. Granulomatous lung disease in a patient with a family history of hematological disorders.
Overbeek MJ; van de Loosdrecht AA; Vonk-Noordegraaf A
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jan; 31(4):350-3. PubMed ID: 25591147
[TBL] [Abstract][Full Text] [Related]
50. Familial platelet disorder with propensity to acute myelogenous leukemia: genetic heterogeneity and progression to leukemia via acquisition of clonal chromosome anomalies.
Minelli A; Maserati E; Rossi G; Bernardo ME; De Stefano P; Cecchini MP; Valli R; Albano V; Pierani P; Leszl A; Sainati L; Lo Curto F; Danesino C; Locatelli F; Pasquali F
Genes Chromosomes Cancer; 2004 Jul; 40(3):165-71. PubMed ID: 15138996
[TBL] [Abstract][Full Text] [Related]
51. Heterogeneity of GATA2-related myeloid neoplasms.
Hirabayashi S; Wlodarski MW; Kozyra E; Niemeyer CM
Int J Hematol; 2017 Aug; 106(2):175-182. PubMed ID: 28643018
[TBL] [Abstract][Full Text] [Related]
52. Familial myelodysplasia and acute myeloid leukaemia--a review.
Owen C; Barnett M; Fitzgibbon J
Br J Haematol; 2008 Jan; 140(2):123-32. PubMed ID: 18173751
[TBL] [Abstract][Full Text] [Related]
53. Clinical utility gene card for: Familial platelet disorder with associated myeloid malignancies.
Ripperger T; Tawana K; Kratz C; Schlegelberger B; Fitzgibbon J; Steinemann D
Eur J Hum Genet; 2016 Aug; 24(8):. PubMed ID: 26813945
[No Abstract] [Full Text] [Related]
54. Diagnosing familial platelet disorder with predisposition to myeloid malignancy: Lessons learned from a germline whole-gene deletion of RUNX1.
Cliburn JA; Uy JC; Swift S; Liesveld JL; Iqbal MA; Jajosky AN; Becker MW
Int J Lab Hematol; 2024 Feb; 46(1):203-206. PubMed ID: 37953439
[No Abstract] [Full Text] [Related]
55. Myeloid malignancies with somatic
Alfayez M; Wang SA; Bannon SA; Kontoyiannis DP; Kornblau SM; Orange JS; Mace EM; DiNardo CD
Leuk Lymphoma; 2019 Aug; 60(8):2025-2033. PubMed ID: 30648453
[TBL] [Abstract][Full Text] [Related]
56. GATA2 germline mutations impair GATA2 transcription, causing haploinsufficiency: functional analysis of the p.Arg396Gln mutation.
Cortés-Lavaud X; Landecho MF; Maicas M; Urquiza L; Merino J; Moreno-Miralles I; Odero MD
J Immunol; 2015 Mar; 194(5):2190-8. PubMed ID: 25624456
[TBL] [Abstract][Full Text] [Related]
57.
Douglas SPM; Siipola P; Kovanen PE; Pyörälä M; Kakko S; Savolainen ER; Salmenniemi U; Orte K; Kytölä S; Pitkänen E; Porkka K; Kilpivaara O; Wartiovaara-Kautto U
Blood; 2019 Jun; 133(25):2724-2728. PubMed ID: 30936069
[No Abstract] [Full Text] [Related]
58. Cancer predisposition syndromes associated with myeloid malignancy.
Quinn E; Nichols KE
Semin Hematol; 2017 Apr; 54(2):115-122. PubMed ID: 28637615
[TBL] [Abstract][Full Text] [Related]
59. Haematological cancer: ETV6 germline mutation - a risk for ALL.
Romero D
Nat Rev Clin Oncol; 2016 Jan; 13(1):4. PubMed ID: 26573422
[No Abstract] [Full Text] [Related]
60. Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations.
Mir MA; Kochuparambil ST; Abraham RS; Rodriguez V; Howard M; Hsu AP; Jackson AE; Holland SM; Patnaik MM
Cancer Med; 2015 Apr; 4(4):490-9. PubMed ID: 25619630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
